Home/Filings/4/0001209191-24-002970
4//SEC Filing

Whalen Kathleen M 4

Accession 0001209191-24-002970

CIK 0000860730other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 7:45 PM ET

Size

20.2 KB

Accession

0001209191-24-002970

Insider Transaction Report

Form 4
Period: 2024-02-05
Whalen Kathleen M
SVP & Chief Ethics Officer
Transactions
  • Exercise/Conversion

    Stock Appreciation Right

    2024-02-054,0400 total
    Exercise: $81.96Exp: 2027-02-01Common Stock (4,040 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2024-02-052,0003,040 total
    Exercise: $101.16Exp: 2028-01-31Common Stock (2,000 underlying)
  • Tax Payment

    Common Stock

    2024-02-05$310.62/sh4,288$1,331,93914,512 total
  • Exercise/Conversion

    Stock Appreciation Right

    2024-02-052,5100 total
    Exercise: $69.58Exp: 2026-01-29Common Stock (2,510 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-05$69.58/sh+2,510$174,64612,760 total
  • Exercise/Conversion

    Common Stock

    2024-02-05$81.96/sh+4,040$331,11816,800 total
  • Exercise/Conversion

    Common Stock

    2024-02-05$101.16/sh+2,000$202,32018,800 total
Footnotes (3)
  • [F1]The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
  • [F2]The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
  • [F3]The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001763910

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 7:45 PM ET
Size
20.2 KB